In this episode of AbbottTalks, hosts Tom Salemi and Kayleen Brown sit down with Dr. Finn Gustafsson, Chief Medical Officer for Abbott’s Heart Failure business, to discuss how Abbott’s technologies are transforming care across every stage of heart failure.

Dr. Gustafsson—who spent decades in academic medicine before joining Abbott—explains how the company’s CentriMag™ System, HeartMate 3™ LVAD, and CardioMEMS™ HF System stabilize, sustain, and empower patients in each phase of the condition. The conversation explores what sets Abbott’s approach apart: early intervention through pulmonary artery pressure monitoring, mechanical circulatory support for critically ill patients, and long-term LVAD therapy that’s helping extend lives beyond five years. Lastly, Dr. Gustafsson shares insights from pivotal studies such as MOMENTUM 3, ARIES, and ASPIRE, which demonstrate how Abbott’s focus on evidence and patient experience is advancing the entire field.

This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/

Thank you for listening to the AbbottTalks podcast!

***

Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

• (00:00:00 ) - Exploring Abbott's Heart Failure Business and Digital Healthcare Innovation
• (00:03:36 ) - Transforming OEMs with Connectivity and Predictive Maintenance
• (00:05:54 ) - Dr. Finn Gustafsson's Journey from Academia to Abbott Heart Failure
• (00:11:20 ) - Understanding Heart Failure and Abbott's Heart Failure Portfolio
• (00:18:03 ) - Heart Monitoring Devices Enhance Patient Care and Empowerment
• (00:25:41 ) - AI-Driven Healthcare Innovation and Regulatory Navigation
• (00:29:20 ) - Advancements and Patient Impact of HeartMate 3 in Heart Failure
• (00:41:19 ) - Reducing Bleeding Risks in HeartMate 3 Patients Without Aspirin
• (00:42:45 ) - Advancements and Future Directions in LVAD Technology and Treatment
• (00:45:16 ) - Exploring MedTech Innovations and Patient Choices in Heart Devices